Sonoma Pharmaceuticals, Inc’s $4.6 million common stock offering

Schiff Hardin advised Dawson James Securities, Inc., as placement agents in the transaction

Sonoma Pharmaceuticals, Inc. operates as a pharmaceutical company. The Company, led by James Schutz, Robert Miller and Marc Umscheid develops and markets solutions for the treatment of dermatological conditions and advanced tissue care. In 2017 the company recorded $12.8 Million Sales.

Schiff Hardin advised with a team including Ralph V. De Martino (Picture), Alec Orudjev and Cavas S. Pavri.

Involved fees earner: Ralph De Martino – Schiff Hardin LLP; Alec Orudjev – Schiff Hardin LLP; Cavas Pavri – Schiff Hardin LLP;

Law Firms: Schiff Hardin LLP;

Clients: Dawson James Securities, Inc.;

Print Friendly, PDF & Email

Author: Ambrogio Visconti